Search

everythinglearnresearchcommunity

for

Search:↓

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Improved care and timely diagnosis are needed for women with PCOD and PCOS, and CystaCare can help.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Glucocorticoids can cause long-term loss of body hair by lowering adrenal androgens.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Most postmenopausal women experience significant skin changes and various skin conditions.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Surgery improved symptoms and normalized hormone levels in a woman with an adrenal tumor.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

Leydig cell tumors can cause hormone issues in postmenopausal women even if imaging looks normal.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.